10 drug approvals to watch for in 2015
This article was originally published in Scrip
Executive Summary
The FDA may have approved the highest number of new molecular entities for 18 years in 2014 (scripintelligence.com, 5 January 2015), but what should we expect for 2015? Here Scrip has taken a look at ten of the more interesting new products set for approval in the US and EU over the coming 12 months, in a rough order of when they are due: